Vertex (VERX) Q3 2026 Earnings Call Transcript

Vertex reported Q3 revenue of $213.3 million, up 11% year over year and above the high end of guidance; adjusted EBITDA rose 49% to $64.8 million, with a 30.4% margin. The company raised full-year 2026 revenue guidance to $828.9 million–$830.9 million and adjusted EBITDA guidance to $217.9 million–$219.9 million, while e-invoicing ARR grew more than 100%. A lost payroll-tax OEM is expected to reduce Q4 GRR and NRR by about 1 point and revenue by roughly $1 million for the quarter; management said this was discrete and reflected in guidance. Vertex repurchased $27 million of shares in Q3 at an average $13.26.

Analysis

The key change is earnings power arriving ahead of the growth proof: cost actions are flowing through faster than recurring growth is accelerating. That supports a higher margin floor, but investors should distinguish durable productivity from underinvestment. Management’s AI-assisted engineering gains matter financially only if they sustain product delivery and retention while R&D capacity is redeployed; code throughput alone is not monetization. Similarly, Vertex Sol’s pricing is mixed between included and paid features, so do not capitalize the launch as incremental ARPU before attach rates or expansion data emerge.

E-invoicing is the strongest medium-term growth lever, but >100% growth is not yet evidence of material consolidated contribution. Mandate deadlines in 2027–29 create a multi-quarter pipeline, while implementation and local-provider displacement can delay conversion. Extended SAP migration timelines are a counterweight: compliance demand may be real without arriving on the schedule implied by headline mandates. The payroll OEM loss is a bounded near-term headwind as described by management, but Q4 retention deterioration will test whether it is truly isolated.

Near term, the margin beat and raised outlook are supportive; Q4 EBITDA guidance below Q3 also underscores expense timing and non-linear margins. Over 1–3 months, monitor GRR/NRR, ARR growth, e-invoicing conversion and paid AI adoption. Over 6–18 months, the thesis depends on mandates translating into recurring revenue and platform cross-sell. The contrarian risk is that the market extrapolates a cost-driven margin step-up into a growth reacceleration before those indicators validate it.

Key Decisions for Investors

• Avoid chasing the earnings reaction without checking valuation and the post-print price; consider a staged long VERX entry on weakness rather than treating the quarter as proof of a durable growth re-rating. Upside: recurring growth and margins compound together; downside: growth stalls while elevated margins prove partly investment-dependent.
• Use the next two reports as confirmation points: require ARR growth to hold or improve and core retention to stabilize after the expected Q4 OEM-related decline. A broader GRR/NRR deterioration, or weaker guidance beyond the disclosed OEM impact, falsifies the isolated-loss thesis and warrants reducing exposure.
• Track e-invoicing ARR, mandate-related customer go-lives, and paid Vertex Sol attach/expansion—not product announcements alone. Slower Germany-related conversion or no evidence of monetization would weaken the 6–18 month upside case; stronger recurring contribution would support adding.
• Treat buybacks as supportive but not a valuation signal. Verify cash conversion and investment levels alongside adjusted EBITDA; a reversal in free-cash-flow conversion or renewed cuts to product capacity would challenge the margin-quality thesis.